These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 22406239)

  • 1. Synergistic antidepressant-like action of gaboxadol and escitalopram.
    Christensen T; Bétry C; Mnie-Filali O; Etievant A; Ebert B; Haddjeri N; Wiborg O
    Eur Neuropsychopharmacol; 2012 Oct; 22(10):751-60. PubMed ID: 22406239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hippocampal GABAergic dysfunction in a rat chronic mild stress model of depression.
    Holm MM; Nieto-Gonzalez JL; Vardya I; Henningsen K; Jayatissa MN; Wiborg O; Jensen K
    Hippocampus; 2011 Apr; 21(4):422-33. PubMed ID: 20087886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities.
    Sánchez C; Bergqvist PB; Brennum LT; Gupta S; Hogg S; Larsen A; Wiborg O
    Psychopharmacology (Berl); 2003 Jun; 167(4):353-62. PubMed ID: 12719960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of the dorsal raphe nucleus-prefrontal cortex serotonin system by chronic treatment with escitalopram in hyposerotonergic Wistar-Kyoto rats.
    Yamada M; Kawahara Y; Kaneko F; Kishikawa Y; Sotogaku N; Poppinga WJ; Folgering JH; Dremencov E; Kawahara H; Nishi A
    Neuropharmacology; 2013 Sep; 72():169-78. PubMed ID: 23643754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Escitalopram: a selective inhibitor and allosteric modulator of the serotonin transporter].
    Mnie-Filali O; El Mansari M; Scarna H; Zimmer L; Sánchez C; Haddjeri N
    Encephale; 2007 Dec; 33(6):965-72. PubMed ID: 18789789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olanzapine augments the effect of selective serotonin reuptake inhibitors by suppressing GABAergic inhibition via antagonism of 5-HT₆ receptors in the dorsal raphe nucleus.
    Asaoka N; Nagayasu K; Nishitani N; Yamashiro M; Shirakawa H; Nakagawa T; Kaneko S
    Neuropharmacology; 2015 Aug; 95():261-8. PubMed ID: 25863120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective serotonin reuptake inhibitors potentiate the rapid antidepressant-like effects of serotonin4 receptor agonists in the rat.
    Lucas G; Du J; Romeas T; Mnie-Filali O; Haddjeri N; Piñeyro G; Debonnel G
    PLoS One; 2010 Feb; 5(2):e9253. PubMed ID: 20169084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanisms of action of antidepressants: new data from Escitalopram].
    Fabre V; Hamon M
    Encephale; 2003; 29(3 Pt 1):259-65. PubMed ID: 12876551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. R-citalopram prevents the neuronal adaptive changes induced by escitalopram.
    Mnie-Filali O; Faure C; Mansari ME; Lambás-Señas L; Bérod A; Zimmer L; Sánchez C; Haddjeri N
    Neuroreport; 2007 Oct; 18(15):1553-6. PubMed ID: 17885600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressant treatment in helpless rats: effect on the electrophysiological activity of raphe dorsalis serotonergic neurons.
    Maudhuit C; Prévot E; Dangoumau L; Martin P; Hamon M; Adrien J
    Psychopharmacology (Berl); 1997 Apr; 130(3):269-75. PubMed ID: 9151362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 17β-Estradiol augments antidepressant efficacy of escitalopram in ovariectomized rats: Neuroprotective and serotonin reuptake transporter modulatory effects.
    Ibrahim WW; Safar MM; Khattab MM; Agha AM
    Psychoneuroendocrinology; 2016 Dec; 74():240-250. PubMed ID: 27685339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. R-citalopram counteracts the antidepressant-like effect of escitalopram in a rat chronic mild stress model.
    Sánchez C; Gruca P; Papp M
    Behav Pharmacol; 2003 Sep; 14(5-6):465-70. PubMed ID: 14501259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the potential antidepressant OPC-14523 [1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2-quinolinone monomethanesulfonate] a combined sigma and 5-HT1A ligand: modulation of neuronal activity in the dorsal raphe nucleus.
    Bermack JE; Haddjeri N; Debonnel G
    J Pharmacol Exp Ther; 2004 Aug; 310(2):578-83. PubMed ID: 15044555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers of anhedonic-like behavior, antidepressant drug refraction, and stress resilience in a rat model of depression.
    Christensen T; Bisgaard CF; Wiborg O
    Neuroscience; 2011 Nov; 196():66-79. PubMed ID: 21889970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined α7 nicotinic acetylcholine receptor agonism and partial serotonin transporter inhibition produce antidepressant-like effects in the mouse forced swim and tail suspension tests: a comparison of SSR180711 and PNU-282987.
    Andreasen JT; Redrobe JP; Nielsen EØ
    Pharmacol Biochem Behav; 2012 Jan; 100(3):624-9. PubMed ID: 22108649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.
    Mansari ME; Wiborg O; Mnie-Filali O; Benturquia N; Sánchez C; Haddjeri N
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):31-40. PubMed ID: 16448580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram.
    Arborelius L; Nomikos GG; Hertel P; Salmi P; Grillner P; Höök BB; Hacksell U; Svensson TH
    Naunyn Schmiedebergs Arch Pharmacol; 1996 May; 353(6):630-40. PubMed ID: 8738296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antidepressant- and anxiolytic-like effects following co-treatment with escitalopram and risperidone in rats.
    Kaminska K; Rogoz Z
    J Physiol Pharmacol; 2016 Jun; 67(3):471-80. PubMed ID: 27512008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-HT1A receptor antagonists increase the activity of serotonergic cells in the dorsal raphe nucleus in rats treated acutely or chronically with citalopram.
    Arborelius L; Nomikos GG; Grillner P; Hertel P; Höök BB; Hacksell U; Svensson TH
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Aug; 352(2):157-65. PubMed ID: 7477438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced 5-HT1A- and GABAB receptor function in dorsal raphé neurons upon chronic fluoxetine treatment of socially stressed rats.
    Cornelisse LN; Van der Harst JE; Lodder JC; Baarendse PJ; Timmerman AJ; Mansvelder HD; Spruijt BM; Brussaard AB
    J Neurophysiol; 2007 Jul; 98(1):196-204. PubMed ID: 17460100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.